Peptides in the brain: the new endocrinology of the neuron.

A. The Existence of Brain Peptides Controlling Adenohypophvsial Functions. Isolation and Characterization of Their Primary Molecular Structures In the early 1950s based on the anatomical observations and physiological experimentation from several groups in the USA and Europe, it became abundantly clear that the endocrine secretions of the anterior lobe of the hypophysis-well known by then to control all the functions of all the target endocrine glands, (thyroid, gonads, adrenal cortex) plus the overall somatic growth of the individual-were somehow entirely regulated by some integrative mechanism located in neuronal elements of the ventral hypothalamus (review Harris, 1955). Because of the peculiar anatomy of the junctional region between ventral hypothalamus (floor of the 3rd ventricle) and the parenchymal tissue of the anterior lobe of the pituitary (Fig. 1), the mechanisms involved in this hypothalamic control of adenohypophysial functions were best explained by proposing the existence of some secretory product(s) by some (uncharacterized) neuronal elements of the ventral hypothalamus, the products of which would somehow reach the adenohypophysis by the peculiar capillary vessels observed as if to join the floor of the hypothalamus to the pituitary gland. That concept was definitely ascertained in simple experiments using combined tissue cultures of fragments of the pituitary gland and of the ventral hypothalamus (Guillemin and Rosenberg, 1955). The search for characterizing the hypothetical hypothalamic hypophysiotropic factors started then. Simple reasoning and early chemical confirmation led to the hypothesis that these unknown substances would be small peptides. After several years of pilot studies involving both biology and relatively simple chemistry in several laboratories in the USA, Europe and Japan, it became clear that characterizing these hypothalamic hypophysiotropic substances would be a challenge of (originally) unsuspected proportions. Entirely novel bioassays would have to be devised for routine testing of a large number of fractions generated by the chemical purification schemes; more sobering still was the realization in the early 1960s that enormous amounts of hypothalamic fragments (from slaughter house animals) would have to be obtained to have available a sufficient quantity of starting material to attempt a meaningful program of chemical isolation. The early pilot studies had indeed shown the hypothalamic sub-

[1]  R. Peters Vitamins and Hormones , 1946, Nature.

[2]  Stern Bt,et al.  EXCERPTA MEDICA. , 1974, Canadian Medical Association journal.

[3]  F. Young Biochemistry , 1955, The Indian Medical Gazette.

[4]  R. Guillemin,et al.  Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures. , 1955, Endocrinology.

[5]  S. Mccann,et al.  LH-Releasing Activity in Hypothalamic Extracts , 1960 .

[6]  R. Guillemin,et al.  IN VITRO SECRETION OF THYROTROPIN (TSH): STIMULATION BY A HYPOTHALAMIC PEPTIDE (TRF). , 1963, Endocrinology.

[7]  S. Mccann,et al.  FURTHER STUDIES ON THE FOLLICLE-STIMULATING HORMONE-RELEASING ACTION OF HYPOTHALAMIC EXTRACTS. , 1964, Endocrinology.

[8]  R. Guillemin HYPOTHALAMIC FACTORS RELEASING PITUITARY HORMONES. , 1964, Recent progress in hormone research.

[9]  W. White,et al.  Purification of follicle-stimulating hormone-releasing factor (FSH-RF) from bovine hypothalamus. , 1966, Endocrinology.

[10]  A. Schally,et al.  Isolation of thyrotropin releasing factor (TRF) from porcine hypothalamus. , 1966, Biochemical and biophysical research communications.

[11]  S. Mccann,et al.  Chromatographic Behavior of Follicle Stimulating Hormone-Releasing Factor on Sephadex and Carboxy Methyl Cellulose , 1967 .

[12]  A. Pearse Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid and ultimobranchial C cells and calcitonin , 1968, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[13]  L. Krulich,et al.  Effect of GH-releasing factor and GH-inhibiting factor on the release and concentration of GH in pituitaries incubated in vitro. , 1969, Endocrinology.

[14]  A. Schally,et al.  Discovery of modification of the synthetic tripeptide-sequence of the thyrotropin releasing hormone having activity. , 1969, Biochemical and biophysical research communications.

[15]  A. Schally,et al.  Isolation and properties of porcine thyrotropin-releasing hormone. , 1969, The Journal of biological chemistry.

[16]  A. Schally,et al.  Structure of porcine thyrotropin releasing hormone. , 1970, Biochemistry.

[17]  R. Guillemin,et al.  Preliminary observations on the effect of synthetic thyrotropin releasing factor on plasma thyrotropin levels in man. , 1970, The Journal of clinical endocrinology and metabolism.

[18]  R. Guillemin,et al.  Biological activity of synthetic polypeptide derivatives related to the structure of hypothalamic TRF. , 1970, Endocrinology.

[19]  R. Guillemin,et al.  Characterization of Ovine Hypothalamic Hypophysiotropic TSH-releasing Factor , 1970, Nature.

[20]  D. Gillessen,et al.  Synthese des «Thyrotropin‐releasing» Hormons (TRH) (Schaf) und verwandter Peptide , 1970 .

[21]  A. Schally,et al.  Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. , 1971, Biochemical and biophysical research communications.

[22]  A. Schally,et al.  Isolation of the luteinizing hormone and follicle-stimulating hormone-releasing hormone from porcine hypothalami. , 1971, The Journal of biological chemistry.

[23]  A. Schally,et al.  Isolation and properties of the FSH and LH-releasing hormone. , 1971, Biochemical and biophysical research communications.

[24]  A. Tashjian,et al.  Thyrotropin releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture. , 1971, Biochemical and biophysical research communications.

[25]  A. Schally,et al.  Synthesis of the porcine LH- and FSH-releasing hormone by the solid-phase method. , 1971, Biochemical and biophysical research communications.

[26]  R. Guillemin,et al.  The hypothalamic hypophysiotropic thyrotropin-releasing factor. , 1971, Vitamins and hormones.

[27]  G. Milne,et al.  Use of chemical ionization mass spectrometry in analysis of amino acid phenylthiohydantoin derivatives formed during Edman degradation of proteins. , 1971, Analytical biochemistry.

[28]  R. Guillemin,et al.  Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin. , 1971, Biochemical and biophysical research communications.

[29]  A. Schally,et al.  The amino acid sequence of a peptide with growth hormone-releasing activity isolated from porcine hypothalamus. , 1971, The Journal of biological chemistry.

[30]  D. Veber,et al.  Synthesis of a proposed growth hormone releasing factor. , 1971, Biochemical and biophysical research communications.

[31]  N. Ling,et al.  Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation). , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Guillemin,et al.  Culture of Enzymatically Dispersed Anterior Pituitary Cells: Functional Validation of a Method , 1972 .

[33]  D. Henning Metabolism , 1972, Introduction to a Phenomenology of Life.

[34]  R Guillemin,et al.  Synthetic Polypeptide Antagonists of the Hypothalamic Luteinizing Hormone Releasing Factor , 1972, Science.

[35]  N. Ling,et al.  Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone , 1973, Science.

[36]  N. Ling,et al.  Direct sequence determination of ovine luteinizing hormone releasing factor by mass spectrometry. , 1973, Biochemistry.

[37]  G. C. Moriarty ADENOHYPOPHYSIS: ULTRASTRUCTURAL CYTOCHEMISTRY A REVIEW , 1973, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[38]  S. Snyder,et al.  Opiate Receptor: Demonstration in Nervous Tissue , 1973, Science.

[39]  R. Guillemin,et al.  Gonadotropin responses to synthetic LRF: dose-response relationship in men. , 1973, The Journal of clinical endocrinology and metabolism.

[40]  W. Vale,et al.  Synthetic analogs of the hypothalamic luteinizing hormone releasing factor with increased agonist or antagonist properties. , 1973, Biochemistry.

[41]  N. Ling,et al.  Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[42]  N. Maclaren,et al.  Advances in human growth hormone research. , 1974, Federation proceedings.

[43]  C. H. Mortimer,et al.  Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. , 1974, Lancet.

[44]  C. J. Goodner,et al.  Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas , 1974, Science.

[45]  R. Guillemin,et al.  Inhibition of growth hormone secretion in the rat by synthetic somatostatin. , 1974, Endocrinology.

[46]  H. S. Tager,et al.  Peptide hormones. , 1974, Annual review of biochemistry.

[47]  W. White,et al.  Some analogs of luteinizing hormone releasing hormone (LH-RH) having intense ovulation-inducing activity. , 1974, Biochemical and biophysical research communications.

[48]  R. Guillemin,et al.  Effects of somatostatin on the secretion of thyrotropin and prolactin. , 1974, Endocrinology.

[49]  R. Guillemin,et al.  Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications. , 1974, The New England journal of medicine.

[50]  J. Rivier Somatostatin. Total solid phase synthesis. , 1974, Journal of the American Chemical Society.

[51]  N. Marks,et al.  Inactivation of somatostatin (GH‐RIH) and its analogs by crude and partially purified rat brain extracts , 1975, FEBS letters.

[52]  H. Morris,et al.  Identification of two related pentapeptides from the brain with potent opiate agonist activity , 1975, Nature.

[53]  T. Hökfelt,et al.  Immunohistochemical evidence for the presence of somatostatin, a powerful inhibitory peptide, in some primary sensory neurons , 1975, Neuroscience Letters.

[54]  L. Terenius,et al.  Morphine-like ligand for opiate receptors in human CSF. , 1975, Life sciences.

[55]  S. Snyder,et al.  An endogenous morphine-like factor in mammalian brain. , 1975, Life sciences.

[56]  J. Hughes Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine , 1975, Brain Research.

[57]  M. Dubois Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[58]  A. Goldstein,et al.  A peptide-like substance from pituitary that acts like morphine. I. Isolation. , 1975, Life sciences.

[59]  A. Pert,et al.  (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic. , 1976, Science.

[60]  F. Norris,et al.  Enkephalin-induced depression of single neurons in brain areas with opiate receptors--antagonism by naloxone. , 1976, Science.

[61]  W. Zieglgänsberger,et al.  Enkephalin-induced inhibition of cortical neurones and the lack of this effect in morphine tolerant/dependent rats , 1976, Brain Research.

[62]  H. Loh,et al.  beta-endorphin is a potent analgesic agent. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[63]  R. Guillemin Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus. , 1976, Endocrinology.

[64]  L. Stein,et al.  Analgesia induced in vivo by central administration of enkephalin in rat , 1976, Nature.

[65]  R. Rosenberg,et al.  Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. , 1976, Science.

[66]  A. Dray,et al.  Effects of enkephalin and morphine on Renshaw cells in feline spinal cord , 1976, Nature.

[67]  C. Li,et al.  Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[68]  N. Ling,et al.  Isolation, primary structure, and synthesis of α-endorphin and γ-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity , 1976 .

[69]  F. Cardinaux,et al.  Evidence for analgesic activity of enkephalin in the mouse , 1976, Nature.

[70]  R. Hill,et al.  Depression of nociceptive and other neurones in the brain by iontophoretically applied met-enkephalin , 1976, Nature.

[71]  F. Bloom,et al.  Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. , 1976, Science.

[72]  R. Guillemin,et al.  Somatostatin: physiological and clinical significance. , 1976, Annual review of medicine.

[73]  A. Goldstein,et al.  Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[74]  E. Hulme,et al.  C fragment of lipotropin has a high affinity for brain opiate receptors , 1976, Nature.

[75]  N. Ling,et al.  beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[76]  M Goldstein,et al.  Occurrence of somatostatin-like immunoreactivity in some peripheral sympathetic noradrenergic neurons. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[77]  P. Petrusz,et al.  Synaptic terminals with somatostatin-like immunoreactivity in the rat brain , 1977, Brain Research.

[78]  N. Ling,et al.  β-ENDORPHIN STIMULATES SECRETION OF ARGININE VASOPRESSIN IN VIVO , 1977 .

[79]  F. Bloom,et al.  Characterization of the endorphins, novel hypothalamic and neurohypophysial peptides with opiate-like activity: evidence that they induce profound behavioral changes , 1977, Psychoneuroendocrinology.

[80]  F. Bloom,et al.  THE ENDORPHINS, NOVEL PEPTIDES OF BRAIN AND HYPOPHYSIAL ORIGIN, WITH OPIATE‐LIKE ACTIVITY: BIOCHEMICAL AND BIOLOGIC STUDIES , 1977, Annals of the New York Academy of Sciences.

[81]  S. Benjannet,et al.  A β‐LPH PRECURSOR MODEL: RECENT DEVELOPMENTS CONCERNING MORPHINE‐LIKE SUBSTANCES , 1977, Annals of the New York Academy of Sciences.

[82]  N. Ling,et al.  Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. , 1977, Endocrinology.

[83]  F. Bloom,et al.  Endorphins are located in the intermediate and anterior lobes of the pituitary gland, not in the neurohypophysis. , 1977, Life sciences.

[84]  N. Ling,et al.  Common precursor to corticotropins and endorphins. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[85]  F. Bloom,et al.  Regional dissociation of beta-endorphin and enkephalin contents in rat brain and pituitary. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[86]  F. Bloom,et al.  Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[87]  F. Bloom,et al.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. , 1977, Science.

[88]  J. M. Oshorn Proc. Nat. Acad. Sei , 1978 .

[89]  F. Bloom,et al.  Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[90]  B. Scharrer,et al.  Peptidergic neurons: facts and trends. , 1978, General and comparative endocrinology.

[91]  Amino-terminal extension analogs of methionine-enkephalin. , 1978, Biochemical and biophysical research communications.

[92]  Cathryn M. Lewis,et al.  Psychoneuroendocrinology , 1979, Pharmacology Biochemistry and Behavior.